Your browser doesn't support javascript.
loading
Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer.
Jeon, Myeongjin; Hong, Sungpyo; Cho, Hyoungmin; Park, Hanbyeol; Lee, Soo-Min; Ahn, Soonkil.
Afiliación
  • Jeon M; Research Center, Samjin Pharm. Co., Ltd., Seoul 07794, Republic of Korea.
  • Hong S; Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon 22012, Republic of Korea.
  • Cho H; Research Center, Samjin Pharm. Co., Ltd., Seoul 07794, Republic of Korea.
  • Park H; Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon 22012, Republic of Korea.
  • Lee SM; Research Center, Samjin Pharm. Co., Ltd., Seoul 07794, Republic of Korea.
  • Ahn S; Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon 22012, Republic of Korea.
Curr Issues Mol Biol ; 45(9): 7058-7074, 2023 Aug 24.
Article en En | MEDLINE | ID: mdl-37754230
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Curr Issues Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Curr Issues Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article